Alpha-fetoprotein (AFP) is an oncofetal glycoprotein that has been used as a tumor marker
for hepatocellular carcinoma (HCC) in combination with ultrasound and other imaging …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, in
part because of inadequate early detection strategies. Current recommendations for …

Background: Measurement of serum α‐fetoprotein (AFP) and abdominal ultrasound (US)
examination are used for the early detection of hepatocellular carcinoma (HCC) in chronic …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide. 1
HCC prevalence and attributable mortality in the United States are increasing rapidly, 2, 3 …

Hepatocellular carcinoma (HCC) is one of the most common and deadly tumors worldwide.
Management of HCC depends on reliable biomarkers for screening, diagnosis, and …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with a high
rate of morbidity and mortality. HCC affects approximately one million individuals annually …

Although there is no definitive evidence that hepatocellular carcinoma (HCC) screening in
high-risk groups improves survival, many physicians screen high-risk populations with …

Background & Aims: We conducted a prospective study to evaluate the significance of
simultaneous measurement of 3 currently used tumor markers in the evaluation of tumor …

Hepatocellular carcinoma (HCC) is one of the most prevalent and lethal causes of cancer-
related death worldwide. The treatment of HCC remains challenging and is largely …

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for
Hepatocellular Carcinoma Page 1 1 International Liver Cancer Association (ILCA) White Paper …